Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 8/2016

01-08-2016 | Editorial

Does a learned journal require regular re-vamping?

Author: A. van Belkum

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 8/2016

Login to get access

Excerpt

Many journals exist in our field and they all have their different merits, levels of visibility, and scientific reputation. Although the impact factor (IF) is an important parameter, it is certainly not the only quality determinant of a journal. For instance, the composition of the editorial board reflects the interest of key opinion leaders in a certain research field as promoted by a journal, and this helps to clinically and scientifically position such a journal. We have recently revamped the Advisory Board for the European Journal of Clinical Microbiology & Infectious Diseases. Not because of dissatisfaction with the activities of previous Board members, but simply because being an Advisory Board member involves “activities” and we all have very busy agendas. So we would really like to thank, in alphabetical order, Matthew Falagas, Tim Harrison, Andy Hoepelman, Thierry Naas, Mike Pfaller, Marc Struelens, Ken Waites, Andreas Widmer, and Victor Yu for their past and, hopefully continued, support, albeit that the latter will be in a less formal fashion. We welcome new Board members. Nathan Wildeboer, Jordi Rello, Camilla Rodrigues, and François Vandenesch have kindly accepted to become actively involved in the management of the journal. When inviting the new Board members, we asked them to facilitate the following:
1.
To allow us to “use” their good name and standing in the field of clinical microbiology and infectious diseases to draw attention to the journal and to try and attract good papers in their respective fields of expertise.
 
2.
To ask them to think about possible improvements for the journal, whatever way it comes.
 
3.
If compatible with their busy agendas, to submit (mini) reviews or editorials on topics of their personal interest.
 
4.
To permit us to pick their brains for the possible development of special issues.
 
5.
To ask them to keep the European Journal of Clinical Microbiology & Infectious Diseases in mind if they themselves or their close colleagues submit papers for publication.
 
Literature
1.
go back to reference Gable MS, Gavali S, Radner A, Tilley DH, Lee B, Dyner L, Collins A, Dengel A, Dalmau J, Glaser CA (2009) Anti-NMDA receptor encephalitis: report of ten cases and comparison with viral encephalitis. Eur J Clin Microbiol Infect Dis 28:1421–1429CrossRefPubMedPubMedCentral Gable MS, Gavali S, Radner A, Tilley DH, Lee B, Dyner L, Collins A, Dengel A, Dalmau J, Glaser CA (2009) Anti-NMDA receptor encephalitis: report of ten cases and comparison with viral encephalitis. Eur J Clin Microbiol Infect Dis 28:1421–1429CrossRefPubMedPubMedCentral
2.
go back to reference Krzyściak W, Jurczak A, Kościelniak D, Bystrowska B, Skalniak A (2014) The virulence of Streptococcus mutans and the ability to form biofilms. Eur J Clin Microbiol Infect Dis 33:499–515CrossRefPubMed Krzyściak W, Jurczak A, Kościelniak D, Bystrowska B, Skalniak A (2014) The virulence of Streptococcus mutans and the ability to form biofilms. Eur J Clin Microbiol Infect Dis 33:499–515CrossRefPubMed
3.
go back to reference Reynolds PE (1989) Structure, biochemistry and mechanism of action of glycopeptide antibiotics. Eur J Clin Microbiol Infect Dis 8:943–950CrossRefPubMed Reynolds PE (1989) Structure, biochemistry and mechanism of action of glycopeptide antibiotics. Eur J Clin Microbiol Infect Dis 8:943–950CrossRefPubMed
4.
go back to reference Dunne WM Jr, Westblade LF, Ford B (2012) Next-generation and whole-genome sequencing in the diagnostic clinical microbiology laboratory. Eur J Clin Microbiol Infect Dis 31:1719–1726CrossRefPubMed Dunne WM Jr, Westblade LF, Ford B (2012) Next-generation and whole-genome sequencing in the diagnostic clinical microbiology laboratory. Eur J Clin Microbiol Infect Dis 31:1719–1726CrossRefPubMed
5.
go back to reference Kohno S, Izumikawa K, Yoshida M, Takesue Y, Oka S, Kamei K, Miyazaki Y, Yoshinari T, Kartsonis NA, Niki Y (2013) A double-blind comparative study of the safety and efficacy of caspofungin versus micafungin in the treatment of candidiasis and aspergillosis. Eur J Clin Microbiol Infect Dis 32:387–397CrossRefPubMed Kohno S, Izumikawa K, Yoshida M, Takesue Y, Oka S, Kamei K, Miyazaki Y, Yoshinari T, Kartsonis NA, Niki Y (2013) A double-blind comparative study of the safety and efficacy of caspofungin versus micafungin in the treatment of candidiasis and aspergillosis. Eur J Clin Microbiol Infect Dis 32:387–397CrossRefPubMed
6.
go back to reference Nicodemo AC, Garcia Paez JI (2007) Antimicrobial therapy for Stenotrophomonas maltophilia infections. Eur J Clin Microbiol Infect Dis 26:229–237CrossRefPubMed Nicodemo AC, Garcia Paez JI (2007) Antimicrobial therapy for Stenotrophomonas maltophilia infections. Eur J Clin Microbiol Infect Dis 26:229–237CrossRefPubMed
7.
go back to reference Döring M, Blume O, Haufe S, Hartmann U, Kimmig A, Schwarze C-P, Lang P, Handgretinger R, Müller I (2014) Comparison of itraconazole, voriconazole, and posaconazole as oral antifungal prophylaxis in pediatric patients following allogeneic hematopoietic stem cell transplantation. Eur J Clin Microbiol Infect Dis 33:629–638CrossRefPubMed Döring M, Blume O, Haufe S, Hartmann U, Kimmig A, Schwarze C-P, Lang P, Handgretinger R, Müller I (2014) Comparison of itraconazole, voriconazole, and posaconazole as oral antifungal prophylaxis in pediatric patients following allogeneic hematopoietic stem cell transplantation. Eur J Clin Microbiol Infect Dis 33:629–638CrossRefPubMed
8.
go back to reference Gullo FP, Rossi SA, Sardi JCO, Teodoro VLI, Mendes-Giannini MJS, Fusco-Almeida AM (2013) Cryptococcosis: epidemiology, fungal resistance, and new alternatives for treatment. Eur J Clin Microbiol Infect Dis 32:1377–1391CrossRefPubMed Gullo FP, Rossi SA, Sardi JCO, Teodoro VLI, Mendes-Giannini MJS, Fusco-Almeida AM (2013) Cryptococcosis: epidemiology, fungal resistance, and new alternatives for treatment. Eur J Clin Microbiol Infect Dis 32:1377–1391CrossRefPubMed
9.
go back to reference Torres A, Blasi F, Peetermans WE, Viegi G, Welte T (2014) The aetiology and antibiotic management of community-acquired pneumonia in adults in Europe: a literature review. Eur J Clin Microbiol Infect Dis 33:1065–1079CrossRefPubMedPubMedCentral Torres A, Blasi F, Peetermans WE, Viegi G, Welte T (2014) The aetiology and antibiotic management of community-acquired pneumonia in adults in Europe: a literature review. Eur J Clin Microbiol Infect Dis 33:1065–1079CrossRefPubMedPubMedCentral
10.
go back to reference Gaspar MC, Couet W, Olivier J-C, Pais AACC, Sousa JJS (2013) Pseudomonas aeruginosa infection in cystic fibrosis lung disease and new perspectives of treatment: a review. Eur J Clin Microbiol Infect Dis 32:1231–1252CrossRefPubMed Gaspar MC, Couet W, Olivier J-C, Pais AACC, Sousa JJS (2013) Pseudomonas aeruginosa infection in cystic fibrosis lung disease and new perspectives of treatment: a review. Eur J Clin Microbiol Infect Dis 32:1231–1252CrossRefPubMed
11.
go back to reference Cunha BA (2012) Oral doxycycline for non-systemic urinary tract infections (UTIs) due to P. aeruginosa and other Gram negative uropathogens. Eur J Clin Microbiol Infect Dis 31:2865–2868CrossRefPubMed Cunha BA (2012) Oral doxycycline for non-systemic urinary tract infections (UTIs) due to P. aeruginosa and other Gram negative uropathogens. Eur J Clin Microbiol Infect Dis 31:2865–2868CrossRefPubMed
12.
go back to reference Kothavade RJ, Dhurat RS, Mishra SN, Kothavade UR (2013) Clinical and laboratory aspects of the diagnosis and management of cutaneous and subcutaneous infections caused by rapidly growing mycobacteria. Eur J Clin Microbiol Infect Dis 32:161–188CrossRefPubMed Kothavade RJ, Dhurat RS, Mishra SN, Kothavade UR (2013) Clinical and laboratory aspects of the diagnosis and management of cutaneous and subcutaneous infections caused by rapidly growing mycobacteria. Eur J Clin Microbiol Infect Dis 32:161–188CrossRefPubMed
13.
go back to reference Guiso N, Berbers G, Fry NK, He Q, Riffelmann M, Wirsing von König CH; EU Pertstrain group (2011) What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories. Eur J Clin Microbiol Infect Dis 30:307–312CrossRefPubMed Guiso N, Berbers G, Fry NK, He Q, Riffelmann M, Wirsing von König CH; EU Pertstrain group (2011) What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories. Eur J Clin Microbiol Infect Dis 30:307–312CrossRefPubMed
14.
go back to reference Ahmad A, Khan A, Akhtar F, Yousuf S, Xess I, Khan LA, Manzoor N (2011) Fungicidal activity of thymol and carvacrol by disrupting ergosterol biosynthesis and membrane integrity against Candida. Eur J Clin Microbiol Infect Dis 30:41–50CrossRefPubMed Ahmad A, Khan A, Akhtar F, Yousuf S, Xess I, Khan LA, Manzoor N (2011) Fungicidal activity of thymol and carvacrol by disrupting ergosterol biosynthesis and membrane integrity against Candida. Eur J Clin Microbiol Infect Dis 30:41–50CrossRefPubMed
15.
go back to reference van Hal SJ, Paterson DL, Gosbell IB (2011) Emergence of daptomycin resistance following vancomycin-unresponsive Staphylococcus aureus bacteraemia in a daptomycin-naïve patient—a review of the literature. Eur J Clin Microbiol Infect Dis 30:603–610CrossRefPubMed van Hal SJ, Paterson DL, Gosbell IB (2011) Emergence of daptomycin resistance following vancomycin-unresponsive Staphylococcus aureus bacteraemia in a daptomycin-naïve patient—a review of the literature. Eur J Clin Microbiol Infect Dis 30:603–610CrossRefPubMed
16.
go back to reference Montassier E, Batard E, Gastinne T, Potel G, de La Cochetière MF (2013) Recent changes in bacteremia in patients with cancer: a systematic review of epidemiology and antibiotic resistance. Eur J Clin Microbiol Infect Dis 32:841–850CrossRefPubMed Montassier E, Batard E, Gastinne T, Potel G, de La Cochetière MF (2013) Recent changes in bacteremia in patients with cancer: a systematic review of epidemiology and antibiotic resistance. Eur J Clin Microbiol Infect Dis 32:841–850CrossRefPubMed
17.
go back to reference Dancer SJ (2011) Hospital cleaning in the 21st century. Eur J Clin Microbiol Infect Dis 30:1473–1481CrossRefPubMed Dancer SJ (2011) Hospital cleaning in the 21st century. Eur J Clin Microbiol Infect Dis 30:1473–1481CrossRefPubMed
18.
go back to reference Dubourg G, Lagier JC, Armougom F, Robert C, Hamad I, Brouqui P, Raoult D (2013) The gut microbiota of a patient with resistant tuberculosis is more comprehensively studied by culturomics than by metagenomics. Eur J Clin Microbiol Infect Dis 32:637–645CrossRefPubMed Dubourg G, Lagier JC, Armougom F, Robert C, Hamad I, Brouqui P, Raoult D (2013) The gut microbiota of a patient with resistant tuberculosis is more comprehensively studied by culturomics than by metagenomics. Eur J Clin Microbiol Infect Dis 32:637–645CrossRefPubMed
19.
go back to reference Antinori S, Schifanella L, Corbellino M (2012) Leishmaniasis: new insights from an old and neglected disease. Eur J Clin Microbiol Infect Dis 31:109–118CrossRefPubMed Antinori S, Schifanella L, Corbellino M (2012) Leishmaniasis: new insights from an old and neglected disease. Eur J Clin Microbiol Infect Dis 31:109–118CrossRefPubMed
20.
go back to reference Lambiase A, Catania MR, del Pezzo M, Rossano F, Terlizzi V, Sepe A, Raia V (2011) Achromobacter xylosoxidans respiratory tract infection in cystic fibrosis patients. Eur J Clin Microbiol Infect Dis 30:973–980CrossRefPubMedPubMedCentral Lambiase A, Catania MR, del Pezzo M, Rossano F, Terlizzi V, Sepe A, Raia V (2011) Achromobacter xylosoxidans respiratory tract infection in cystic fibrosis patients. Eur J Clin Microbiol Infect Dis 30:973–980CrossRefPubMedPubMedCentral
21.
go back to reference Wang Q-P, Wu Z-D, Wei J, Owen RL, Lun Z-R (2012) Human Angiostrongylus cantonensis: an update. Eur J Clin Microbiol Infect Dis 31:389–395CrossRefPubMed Wang Q-P, Wu Z-D, Wei J, Owen RL, Lun Z-R (2012) Human Angiostrongylus cantonensis: an update. Eur J Clin Microbiol Infect Dis 31:389–395CrossRefPubMed
Metadata
Title
Does a learned journal require regular re-vamping?
Author
A. van Belkum
Publication date
01-08-2016
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 8/2016
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-016-2720-y

Other articles of this Issue 8/2016

European Journal of Clinical Microbiology & Infectious Diseases 8/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.